Cargando…
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246736/ https://www.ncbi.nlm.nih.gov/pubmed/31989625 http://dx.doi.org/10.1111/all.14200 |
| _version_ | 1783716374302949376 |
|---|---|
| author | Stranzl, Thomas Ipsen, Henrik Christensen, Lars Harder Eiwegger, Thomas Johansen, Niels Lund, Kaare Andersen, Peter Sejer |
| author_facet | Stranzl, Thomas Ipsen, Henrik Christensen, Lars Harder Eiwegger, Thomas Johansen, Niels Lund, Kaare Andersen, Peter Sejer |
| author_sort | Stranzl, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8246736 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82467362021-07-02 Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study Stranzl, Thomas Ipsen, Henrik Christensen, Lars Harder Eiwegger, Thomas Johansen, Niels Lund, Kaare Andersen, Peter Sejer Allergy Letters to the Editor John Wiley and Sons Inc. 2020-02-19 2021-04 /pmc/articles/PMC8246736/ /pubmed/31989625 http://dx.doi.org/10.1111/all.14200 Text en © 2020 The Authors. Allergy published by John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Stranzl, Thomas Ipsen, Henrik Christensen, Lars Harder Eiwegger, Thomas Johansen, Niels Lund, Kaare Andersen, Peter Sejer Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title | Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title_full | Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title_fullStr | Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title_full_unstemmed | Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title_short | Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study |
| title_sort | limited impact of der p 23 ige on treatment outcomes in tablet allergy immunotherapy phase iii study |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246736/ https://www.ncbi.nlm.nih.gov/pubmed/31989625 http://dx.doi.org/10.1111/all.14200 |
| work_keys_str_mv | AT stranzlthomas limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT ipsenhenrik limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT christensenlarsharder limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT eiweggerthomas limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT johansenniels limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT lundkaare limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy AT andersenpetersejer limitedimpactofderp23igeontreatmentoutcomesintabletallergyimmunotherapyphaseiiistudy |